序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
1 用于生产聚-4-羟基丁酸酯的遗传工程生物 CN201380026228.1 2013-03-04 CN104321427A 2015-01-28 W·R·法默; C·W·J·麦克查利彻; T·M·拉姆塞尔; Z·张; D-E·常; J·比克迈耶; J·比利; C·莫泽
本文描述了用于生产聚-4-羟基丁酸酯和4-产物的方法和遗传工程宿主。
2 Fumarate reductases US15103237 2014-12-12 US09944905B2 2018-04-17 René Marcel De Jong; Zheng Zhao; Ben Den Dulk; Remko Tsjibbe Winter
The present invention relates to a variant polypeptide having fumarate reductase activity, which has modified NADP(H)-dependent and/or NAD(H)-dependent activity as compared with a reference polypeptide having fumarate reductase activity. Such a variant may be overexpressed in a host cell in order to improve production of a dicarboxylic acid.
3 L-malate production by metabolically engineered escherichia coli US13819773 2011-09-01 US09187772B2 2015-11-17 Xueli Zhang; Xuan Wang; Keelnatham T. Shanmugam; Lonnie O'Neal Ingram
A process for the production of malic acid in commercially significant quantities from the carbon compounds by genetically modified bacterial strains (GMBS; also referred to as biocatalysts or genetically modified microorganisms) is disclosed. Microorganisms suitable for the production of malic acid can be cultured in one or two-step processes as disclosed herein.
4 ELECTROCHEMICAL BIOREACTOR MODULE AND ENGINEERED METABOLIC PATHWAYS FOR 1- BUTANOL PRODUCTION WITH HIGH CARBON EFFICIENCY EP16756175 2016-02-23 EP3262179A4 2018-07-11 DODDS DAVID R; ARMIGER WILLIAM B; KOFFAS MATTHEOS
A combination of an electrochemical device for delivering reducing equivalents to a cell, and engineered metabolic pathways within the cell capable of utilizing the electrochemically provided reducing equivalents is disclosed. Such a combination allows the production of commodity chemicals by fermentation to proceed with increased carbon efficiency.
5 Compositions and Methods for Succinate Production US15386506 2016-12-21 US20170107526A1 2017-04-20 Kenneth R. FINLEY; Jeanette M. HURYTA; Beth M. MASTEL; Thomas W. MCMULLIN; Gregory M. POYNTER; Brian J. RUSH; Arlene M. FOSMER; Vernon L. MCINTOSH, JR.; Keith M. BRADY; Kevin T. WATTS
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate.
6 Compositions and methods for succinate production US13981517 2012-01-25 US09605285B2 2017-03-28 Kenneth R. Finley; Jeanette M. Huryta; Beth M. Mastel; Thomas W. McMullin; Gregory M. Poynter; Brian J. Rush; Kevin T. Watts; Arlene M. Fosmer; Vernon L. McIntosh, Jr.; Keith M. Brady
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate.
7 COMPOSITIONS AND METHODS FOR SUCCINATE PRODUCTION EP12740007 2012-01-25 EP2668281A4 2015-08-26 CARGILL INCORPORATED; BIOAMBER S A S
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate.
8 Electrochemical Bioreactor Module and Engineered Metabolic Pathways for 1-Butanol Production with High Carbon Efficiency US15552647 2016-02-23 US20180037914A1 2018-02-08 David R. Dodds; William B. Armiger; Mattheos Koffas
A combination of an electrochemical device for delivering reducing equivalents to a cell, and engineered metabolic pathways within the cell capable of utilizing the electrochemically provided reducing equivalents is disclosed. Such a combination allows the production of commodity chemicals by fermentation to proceed with increased carbon efficiency.
9 FUMARATE REDUCTASES US15103237 2014-12-12 US20160319245A1 2016-11-03 René Marcel DE JONG; Zheng ZHAO; Ben DEN DULK; Remko Tsjibbe WINTER
The present invention relates to a variant polypeptide having fumarate reductase activity, which has modified NADP(H)-dependent and/or NAD(H)-dependent activity as compared with a reference polypeptide having fumarate reductase activity. Such a variant may be overexpressed in a host cell in order to improve production of a dicarboxylic acid.
10 Genetically Engineered Microorganisms for the Production of Poly-4-Hydroxybutyrate US14386728 2013-03-04 US20150159184A1 2015-06-11 Thomas M. Ramseier; Christopher W.J. McChalicher; William R. Farmer; Zhigang Zhang; Dong-Eun Chang; Jeff Bickmeier; Julie Beaulieu; Catherine Morse
Methods and genetically engineered hosts for the production of poly-4-hydroxybutrate and 4-carbon products are described herein.
11 COMPOSITIONS AND METHODS FOR SUCCINATE PRODUCTION US13981517 2012-01-25 US20130302866A1 2013-11-14 Kenneth R. Finley; Jeanette M. Huryta; Beth M. Mastel; Thomas W. McMullin; Gregory M. Poynter; Brian J. Rush; Kevin T. Watts; Arlene M. Fosmer; Vernon L. McIntosh, JR.; Keith M. Brady
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate.
12 L-MALATE PRODUCTION BY METABOLICALLY ENGINEERED ESCHERICHIA COLI US13819773 2011-09-01 US20130157330A1 2013-06-20 Xueli Zhang; Xuan Wang; Keelnatham T. Shanmugam; Lonnie O'Neal Ingram
A process for the production of malic acid in commercially significant quantities from the carbon compounds by genetically modified bacterial strains (GMBS; also referred to as biocatalysts or genetically modified microorganisms) is disclosed. Microorganisms suitable for the production of malic acid can be cultured in one or two-step processes as disclosed herein.
13 ELECTROCHEMICAL BIOREACTOR MODULE AND ENGINEERED METABOLIC PATHWAYS FOR 1- BUTANOL PRODUCTION WITH HIGH CARBON EFFICIENCY EP16756175.2 2016-02-23 EP3262179A1 2018-01-03 DODDS, David R.; ARMIGER, William B.; KOFFAS, Mattheos
A combination of an electrochemical device for delivering reducing equivalents to a cell, and engineered metabolic pathways within the cell capable of utilizing the electrochemically provided reducing equivalents is disclosed. Such a combination allows the production of commodity chemicals by fermentation to proceed with increased carbon efficiency.
14 GENETICALLY ENGINEERED MICROORGANISMS FOR THE PRODUCTION OF POLY-4-HYDROXYBUTYRATE EP13710245.5 2013-03-04 EP2828383A1 2015-01-28 FARMER, William, R.; MCCHALICHER, Christopher, W.J.; RAMSEIER, Thomas, M.; ZHANG, Zhigang; CHANG, Dong-Eun; BICKMEIER, Jeff; BEAULIEU, Julie; MORSE, Catherine
Methods and genetically engineered hosts for the production of poly-4-hydroxybutrate and 4-carbon products are described herein.
15 COMPOSITIONS AND METHODS FOR SUCCINATE PRODUCTION EP12740007.5 2012-01-25 EP2668281A2 2013-12-04 Cargill, Incorporated; BioAmber S.A.S.
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate.
16 COMPOSITIONS AND METHODS FOR SUCCINATE PRODUCTION PCT/US2012022612 2012-01-25 WO2012103261A3 2012-11-22 FINLEY KENNETH R; HURYTA JEANETTE M; MASTEL BETH M; MCMULLIN THOMAS W; POYNTER GREGORY M; RUSH BRIAN J; WATTS KEVIN T; FOSMER ARLENE M; MCINTOSH VERNON L JR; BRADY KEITH M
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate.
17 FUMARATE REDUCTASES PCT/EP2014077638 2014-12-12 WO2015086839A9 2016-09-09 JONG DE RENÉ MARCEL; ZHAO ZHENG; DULK DEN BEN; WINTER REMKO TSJIBBE
The present invention relates to a variant polypeptide having fumarate reductase activity, which has modified NADP(H)-dependent and/or NAD(H)-dependent activity as compared with a reference polypeptide having fumarate reductase activity. Such a variant may be overexpressed in a host cell in order to improve production of a dicarboxylic acid.
18 L-MALATE PRODUCTION BY METABOLICALLY ENGINEERED ESCHERICHIA COLI PCT/US2011050146 2011-09-01 WO2012031079A2 2012-03-08 ZHANG XUELI; WANG XUAN; SHANMUGAM KEELNATHAM T; INGRAM LONNIE O'NEAL
A process for the production of malic acid in commercially significant quantities from the carbon compounds by genetically modified bacterial strains (GMBS; also referred to as biocatalysts or genetically modified microorganisms) is disclosed. Microorganisms suitable for the production of malic acid can be cultured in one or two-step processes as disclosed herein.
QQ群二维码
意见反馈